Clinical Trial Update: POF Versus FOLFOX Versus FOLFOX Plus ip Paclitaxel in AGC [Phase 2]

View source ↗

Summary

Phase 2 trial comparing POF, FOLFOX, and FOLFOX plus paclitaxel in advanced gastric cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Stomach Cancer

Drugs mentioned

• FOLFOX
• FOLFOX plus paclitaxel
• POF

Snippet

Sponsor: Fujian Cancer Hospital | Conditions: Malignant Neoplasm of Stomach Stage IV | Phase 2 | Status: COMPLETED